LEGN NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Legend Biotech Corp · Healthcare · Biotechnology

Open interactive chart View report data Download investor PDF
Latest close 22.22 USD
-0.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is -3.7% below the Trend Line and sits at 21.8% of its 52-week range. The latest completed week returned -0.2%, after a -22.6% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 47/100 conviction, while the latest news-sentiment score is 49/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 26 out of 100
Latest Close 22.22 USD 24 Jul 2026
1W Return -0.2% latest completed week
4W Return -22.6% short-term follow-through
12W Return -5.8% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.2% Latest completed week; four-week move -22.6%. Indicator stack 42/42 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 47/100 conviction; expected move 18.6%. News sentiment 49/100 72 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is -3.7% below the Trend Line and sits at 21.8% of its 52-week range. The latest completed week returned -0.2%, after a -22.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7012-week average 0.45

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.70Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -22.6% over four weeks, -5.8% over 12 weeks, and -48.8% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W-0.2%
4W-22.6%
12W-5.8%
26W16.9%
52W-48.8%
Active trend streak8 weeks
Active weeks in one year14
Trend breadth26.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-99.9%Four-week change in activity pressure.
Leadership-23.85Latest relative-leadership reading.
RS change-126.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength3/100Blend of value, momentum, and quality. Underlying universe rank 98; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality6/100Profitability and accounting quality. Underlying universe rank 95; rank 1 is best.
Momentum7/100Medium-term price momentum. Underlying universe rank 94; rank 1 is best.
Growth87/100Revenue and earnings growth. Underlying universe rank 14; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
3.8x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-2.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
55.0%
Gross profit retained from each unit of revenue.
Operating margin
-19.3%
Operating profit retained from revenue.
Free-cash-flow margin
-10.0%
Free cash flow generated from revenue.
Return on invested capital
-23.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
56.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

LEGN shows volatility options pressure with a 47/100 conviction score, put-call volume ratio of 0.59, expected move of 18.6%, and Sharemaestro trend signal active.

Conviction47/100
Expected move18.6%
Put/call volume0.59
Pressure32
Speculation41
Volatility82
Trend agreement60
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 72 relevant articles.

11 positive · 51 neutral · 10 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
Options expected move18.6%Nearest-chain priced movement where available.
52-week drawdown-49.2%Distance below the 52-week high.
13-week volatility12.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+20.1%Week of 5 Jun.
Worst week-22.1%Week of 19 Jun.
Latest week-0.2%Week of 24 Jul.

Shape of recent returns

Strong gains9
Modest gains3
Flat weeks0
Modest losses7
Sharp losses7
Recent vol12.1%13-week weekly-return volatility.
Base vol8.6%52-week weekly-return volatility.
Up/down split20/32Count of positive and negative weeks in the 52-week window.
Average skew7.1% / -5.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape32/100

Trend, activity pressure, participation, and risk combine to a 32/100 tape read.

 Indicator analysis61/100

Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 1/12.

Activity pressure 0.70; No reversal markers Factors8/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 55; Small Cap Core rank 78 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options51/100

LEGN shows volatility options pressure with a 47/100 conviction score, put-call volume ratio of 0.59, expected move of 18.6%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 18.6% Sentiment49/100

Weighted news tone is neutral across 72 relevant articles.

LEGN: Future Returns Expected From Expanding Multiple Myeloma Franchise Execution Insiders50/100

No recent insider transaction evidence is stored.

 Earnings11d

Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202622.22 USD-0.2%23.07 USD41.47 USD0.00-23.859.0MOn
17 Jul 202622.26 USD-17.8%23.08 USD41.81 USD0.35-26.4014.7MOn
10 Jul 202627.08 USD-9.5%23.07 USD42.15 USD0.65-15.776.6MOn
3 Jul 202629.91 USD4.3%22.91 USD42.42 USD0.93-6.635.3MOn
26 Jun 202628.69 USD2.7%22.86 USD42.67 USD1.19-10.5213.3MOn
19 Jun 202627.93 USD-22.1%22.82 USD42.93 USD1.26-17.6118.1MOn
12 Jun 202635.87 USD10.0%22.83 USD43.23 USD1.317.4211.4MOn
5 Jun 202632.62 USD20.1%22.64 USD43.45 USD1.35-0.9027.7MOn
29 May 202627.16 USD-7.5%22.62 USD43.67 USD1.35-21.846.8MOff
22 May 202629.37 USD6.6%22.79 USD43.90 USD1.33-13.727.9MOff
15 May 202627.55 USD-2.0%22.88 USD44.12 USD1.39-18.6115.1MOff
8 May 202628.12 USD19.2%23.02 USD44.39 USD1.28-17.6817.9MOff
1 May 202623.59 USD-1.3%23.14 USD44.66 USD0.99-27.897.8MOff
24 Apr 202623.90 USD12.9%23.42 USD44.94 USD0.82-26.7718.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.